About
Cellens Inc develops a noninvasive, urine-based cancer diagnostics platform that uses nanoscale biophysical markers and machine learning to detect bladder cancer and potentially other cancers from bodily fluids.
Explore Cellens Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.